tenofovir has been researched along with Hepatitis A in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Deng, W; Jiang, T; Li, M; Lin, Y; Lu, Y; Sun, F; Xie, Y; Yang, L; Yi, W; Zhang, L | 1 |
| Barreiro, P; Corral, O; Mendoza, C; Moreno-Torres, V; Soriano, V | 1 |
| Bugnon, S; Godinho, R; Gracin, T; Tataw, J | 1 |
3 other study(ies) available for tenofovir and Hepatitis A
| Article | Year |
|---|---|
Effects of antiviral therapy and drug withdrawal on postpartum hepatitis in pregnant women with chronic HBV infection.
Topics: Antiviral Agents; DNA, Viral; Female; Hepatitis A; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Pregnant Women; Tenofovir; Viral Load | 2023 |
Viral hepatitis in persons living with HIV in the post-COVID era.
Topics: Antiviral Agents; Carcinoma, Hepatocellular; Coinfection; COVID-19; Drug Users; Hepatitis A; Hepatitis B; Hepatitis B, Chronic; Hepatitis C; Hepatitis C, Chronic; HIV Infections; Homosexuality, Male; Humans; Liver Cirrhosis; Liver Neoplasms; Male; Sexual and Gender Minorities; Substance Abuse, Intravenous; Tenofovir | 2023 |
Severe rhabdomyolysis-induced acute kidney injury following concomitant use of Genvoya® (EVG/COBI/FTC/TAF) and simvastatin; a case report.
Topics: Acute Kidney Injury; Anti-HIV Agents; Cobicistat; Drug Combinations; Drug Interactions; Dyslipidemias; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Emtricitabine; Hepatitis A; Hepatitis C; HIV Infections; Humans; Hypolipidemic Agents; Liver Function Tests; Male; Middle Aged; Quinolones; Renal Dialysis; Rhabdomyolysis; Simvastatin; Tenofovir; Treatment Outcome | 2019 |